LFG
PTGX icon

Larson Financial Group’s Protagonist Therapeutics PTGX Stock Holding History

Larson Financial Group’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.3K Buy
819
+648
+379% +$57.4K ﹤0.01% 1065
2025
Q4 		$14.9K Buy
171
+17
+11% +$1.39K ﹤0.01% 1880
2025
Q3 		$10.2K Buy
154
+128
+492% +$7.28K ﹤0.01% 2003
2025
Q2 		$1.44K Sell
26
-100
-79% -$4.8K ﹤0.01% 2528
2025
Q1 		$6.09K Buy
126
+111
+740% +$4.65K ﹤0.01% 1829
2024
Q4 		$579 Sell
15
-2
-12% -$87 ﹤0.01% 2163
2024
Q3 		$765 Buy
+17
New +$687 ﹤0.01% 2042

Other funds holding PTGX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return